Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jeffrey Sklar

EGFRExon 19 Deletion in Pancreatic Adenocarcinoma Responds to Erlotinib, Followed byT790M-Mediated Resistance

Journal of the National Comprehensive Cancer Network : JNCCN

Medicine

Oncology

2017

English

Oncogenic Forms of NOTCH1 Lacking Either the Primary Binding Site for RBP-Jκ or Nuclear Localization Sequences Retain the Ability to Associate With RBP-Jκ and Activate Transcription

Journal of Biological Chemistry

English

Related publications

Combination of Crizotinib and Osimertinib or Erlotinib Might Overcome MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutated Adenocarcinoma

Journal of Thoracic Oncology

English

P3.13-19 Surgery for cIIIB Lung Adenocarcinoma After Response to Erlotinib, Survival and Management of Postoperative Oligoprogressions

Journal of Thoracic Oncology

English

Prospective Assessment of Discontinuation and Reinitiation of Erlotinib or Gefitinib in Patients With Acquired Resistance to Erlotinib or Gefitinib Followed by the Addition of Everolimus

Clinical Cancer Research

Cancer Research

Oncology

2007

English

Reply To: Relationship Between LAT1 Expression and Resistance to Chemotherapy in Pancreatic Ductal Adenocarcinoma

Cancer Chemotherapy and Pharmacology

English

Prolonged Response to First-Line Erlotinib for Advanced Lung Adenocarcinoma

Journal of Experimental and Clinical Cancer Research

Cancer Research

Oncology

2008

English

Image-Based Detection and Targeting of Therapy Resistance in Pancreatic Adenocarcinoma

Nature

Multidisciplinary

2016

English

Pancreatic Adenocarcinoma

2008

English

Induction of ADAM10 Drives Fibrosis and Therapeutic Resistance in Response to SBRT in Pancreatic Ductal Adenocarcinoma

International Journal of Radiation Oncology Biology Physics

English

P3.03-12 Cyclic Mechanical Strain and Myoferlin Modulates Lung Adenocarcinoma Cell Proliferation and Erlotinib Resistance

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jeffrey Sklar

EGFRExon 19 Deletion in Pancreatic Adenocarcinoma Responds to Erlotinib, Followed byT790M-Mediated Resistance

Oncogenic Forms of NOTCH1 Lacking Either the Primary Binding Site for RBP-Jκ or Nuclear Localization Sequences Retain the Ability to Associate With RBP-Jκ and Activate Transcription

Related publications

Combination of Crizotinib and Osimertinib or Erlotinib Might Overcome MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutated Adenocarcinoma

P3.13-19 Surgery for cIIIB Lung Adenocarcinoma After Response to Erlotinib, Survival and Management of Postoperative Oligoprogressions

Prospective Assessment of Discontinuation and Reinitiation of Erlotinib or Gefitinib in Patients With Acquired Resistance to Erlotinib or Gefitinib Followed by the Addition of Everolimus

Reply To: Relationship Between LAT1 Expression and Resistance to Chemotherapy in Pancreatic Ductal Adenocarcinoma

Prolonged Response to First-Line Erlotinib for Advanced Lung Adenocarcinoma

Image-Based Detection and Targeting of Therapy Resistance in Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

Induction of ADAM10 Drives Fibrosis and Therapeutic Resistance in Response to SBRT in Pancreatic Ductal Adenocarcinoma

P3.03-12 Cyclic Mechanical Strain and Myoferlin Modulates Lung Adenocarcinoma Cell Proliferation and Erlotinib Resistance